世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

高純度タキシホリン - 世界市場シェア・ランキング、全体売上高・需要予測 2025-2031

高純度タキシホリン - 世界市場シェア・ランキング、全体売上高・需要予測 2025-2031


High Purity Taxifolin - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

世界の高純度タキシホリン市場規模は2024年に2674万米ドルと評価され、2025-2031年の予測期間中にCAGR 4.06%で2031年までに3566万米ドルに達すると予測されている。 高純度タキシフォリンの世界の主要企業には... もっと見る

 

 

出版社 出版年月 電子版価格 納期 言語
QYResearch
QYリサーチ
2025年5月12日 US$3,950
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
5-7営業日 英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

サマリー

世界の高純度タキシホリン市場規模は2024年に2674万米ドルと評価され、2025-2031年の予測期間中にCAGR 4.06%で2031年までに3566万米ドルに達すると予測されている。

高純度タキシフォリンの世界の主要企業には、Ametis JSC、Jilin Jianwei Natural Biotechnology、Kalenika Group、ROBIOS、Xi'an Sost Biotech Co.Ltd、Focusherb、Hoycomeなどが含まれる。2024年には、世界の大手5社が売上高で約91%のシェアを占めている。
本レポートでは、高純度タキシホリンの世界市場について、地域・国別、タイプ別、用途別の分析とともに、総販売量、販売収益、価格、主要企業の市場シェア、ランキングを中心に包括的に紹介することを目的としています。
高純度タキシホリンの市場規模、推計、予測は、2024年を基準年として、2020年から2031年までの期間の履歴データおよび予測データとともに、販売量(kg)および販売収益(百万ドル)で提供されます。定量分析および定性分析により、読者がビジネス/成長戦略を策定し、市場競争状況を評価し、現在の市場における自社のポジションを分析し、高純度タキシホリンに関する十分な情報に基づいたビジネス上の意思決定を行えるよう支援します。

市場区分
企業別
アメティスJSC
Jilin Jianwei Natural Biotechnology社
カレニカ・グループ
ロビオス
西安ソストバイオテック株式会社
フォーカスハーブ
ホイカム
ハーブケムバイオテック

タイプ別セグメント
92%- 98%
98%以上

用途別セグメント
ヘルスケア
食品・飲料
化粧品
その他

地域別
北米
アメリカ
カナダ
メキシコ

アジア太平洋
中国
日本
韓国
東南アジア
インド
その他のアジア太平洋地域

欧州
ドイツ
フランス
英国
イタリア
ロシア
その他のヨーロッパ

南米
ブラジル
その他の南米諸国

中東・アフリカ
中東
アフリカ

各章の概要
第1章: レポートの対象範囲、世界の総市場規模(金額、数量、価格)を紹介します。また、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界メーカーが直面する課題とリスク、業界の関連政策の分析などを提供します。
第2章:高純度タキシホリンメーカーの競争環境、価格、売上高、市場シェアなどの詳細分析
第3章:各種市場セグメントをタイプ別に分析し、各市場セグメントの市場規模や発展可能性を網羅し、読者が各市場セグメントのブルーオーシャン市場を見つけやすくします。
第4章:アプリケーション別の様々な市場セグメントの分析を提供し、各市場セグメントの市場規模と発展可能性をカバーし、読者が異なる下流市場のブルーオーシャン市場を見つけるのに役立ちます。
第5章:地域レベルでの高純度タキシホリンの売上高、収益。各地域の市場規模と発展可能性を定量的に分析し、世界各国の市場発展、将来発展見込み、市場空間、市場規模を紹介しています。
第6章 高純度タキシホリンの国別売上高、収益。各国・地域のタイプ別、用途別のシグメイトデータを提供。
第7章:主要企業のプロファイルを提供し、製品の売上高、収益、価格、売上総利益率、製品紹介、最近の開発など、市場の主要企業の基本的な状況を詳細に紹介します。
第8章:産業の上流と下流を含む産業チェーンの分析。
第9章:結論

ページTOPに戻る


目次

1 Market Overview 1
1.1 High Purity Taxifolin Product Introduction 1
1.2 Global High Purity Taxifolin Market Size Forecast 2
1.2.1 Global High Purity Taxifolin Sales Value (2020-2031) 2
1.2.2 Global High Purity Taxifolin Sales Volume (2020-2031) 3
1.2.3 Global High Purity Taxifolin Sales Price (2020-2031) 5
1.3 High Purity Taxifolin Market Trends & Drivers 5
1.3.1 High Purity Taxifolin Industry Trends 5
1.3.2 High Purity Taxifolin Market Drivers & Opportunity 6
1.3.3 High Purity Taxifolin Market Challenges 7
1.3.4 High Purity Taxifolin Market Restraints 7
1.4 Assumptions and Limitations 8
1.5 Study Objectives 9
1.6 Years Considered 10
2 Competitive Analysis by Company 11
2.1 Global High Purity Taxifolin Players Revenue Ranking (2024) 11
2.2 Global High Purity Taxifolin Revenue by Company (2020-2025) 12
2.3 Global High Purity Taxifolin Players Sales Volume Ranking (2024) 13
2.4 Global High Purity Taxifolin Sales Volume by Company Players (2020-2025) 14
2.5 Global High Purity Taxifolin Average Price by Company (2020-2025) 16
2.6 Key Manufacturers High Purity Taxifolin Manufacturing Base and Headquarters 16
2.7 Key Manufacturers High Purity Taxifolin Product Offered 17
2.8 Key High Purity Taxifolin Manufacturers, Established Time 17
2.9 High Purity Taxifolin Market Competitive Analysis 18
2.9.1 High Purity Taxifolin Market Concentration Rate (2020-2025) 18
2.9.2 Global 3 and 5 Largest Manufacturers by High Purity Taxifolin Revenue in 2024 19
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in High Purity Taxifolin as of 2024) 20
3 Segmentation by Type 22
3.1 Introduction by Type 22
3.1.1 92%- 98% 22
3.1.2 Above 98% 22
3.2 Global High Purity Taxifolin Sales Value by Type 22
3.2.1 Global High Purity Taxifolin Sales Value by Type (2020 VS 2024 VS 2031) 23
3.2.2 Global High Purity Taxifolin Sales Value, by Type (2020-2031) 24
3.2.3 Global High Purity Taxifolin Sales Value, by Type (%) (2020-2031) 25
3.3 Global High Purity Taxifolin Sales Volume by Type 26
3.3.1 Global High Purity Taxifolin Sales Volume by Type (2020 VS 2024 VS 2031) 26
3.3.2 Global High Purity Taxifolin Sales Volume, by Type (2020-2031) 28
3.3.3 Global High Purity Taxifolin Sales Volume, by Type (%) (2020-2031) 28
3.4 Global High Purity Taxifolin Average Price by Type (2020-2031) 29
4 Segmentation by Application 31
4.1 Introduction by Application 31
4.1.1 Healthcare 31
4.1.2 Food and Beverage 31
4.1.3 Cosmetics 32
4.1.4 Others 33
4.2 Global High Purity Taxifolin Sales Value by Application 34
4.2.1 Global High Purity Taxifolin Sales Value by Application (2020 VS 2024 VS 2031) 34
4.2.2 Global High Purity Taxifolin Sales Value, by Application (2020-2031) 36
4.2.3 Global High Purity Taxifolin Sales Value, by Application (%) (2020-2031) 37
4.3 Global High Purity Taxifolin Sales Volume by Application 38
4.3.1 Global High Purity Taxifolin Sales Volume by Application (2020 VS 2024 VS 2031) 38
4.3.2 Global High Purity Taxifolin Sales Volume, by Application (2020-2031) 40
4.3.3 Global High Purity Taxifolin Sales Volume, by Application (%) (2020-2031) 41
4.4 Global High Purity Taxifolin Average Price by Application (2020-2031) 42
5 Segmentation by Region 44
5.1 Global High Purity Taxifolin Sales Value by Region 44
5.1.1 Global High Purity Taxifolin Sales Value by Region: 2020 VS 2024 VS 2031 44
5.1.2 Global High Purity Taxifolin Sales Value by Region (2020-2025) 44
5.1.3 Global High Purity Taxifolin Sales Value by Region (2026-2031) 45
5.1.4 Global High Purity Taxifolin Sales Value by Region (%), (2020-2031) 45
5.2 Global High Purity Taxifolin Sales Volume by Region 46
5.2.1 Global High Purity Taxifolin Sales Volume by Region: 2020 VS 2024 VS 2031 46
5.2.2 Global High Purity Taxifolin Sales Volume by Region (2020-2025) 47
5.2.3 Global High Purity Taxifolin Sales Volume by Region (2026-2031) 47
5.2.4 Global High Purity Taxifolin Sales Volume by Region (%), (2020-2031) 48
5.3 Global High Purity Taxifolin Average Price by Region (2020-2031) 49
5.4 North America 50
5.4.1 North America High Purity Taxifolin Sales Value, 2020-2031 50
5.4.2 North America High Purity Taxifolin Sales Value by Country (%), 2024 VS 2031 51
5.5 Europe 52
5.5.1 Europe High Purity Taxifolin Sales Value, 2020-2031 52
5.5.2 Europe High Purity Taxifolin Sales Value by Country (%), 2024 VS 2031 53
5.6 Asia Pacific 54
5.6.1 Asia Pacific High Purity Taxifolin Sales Value, 2020-2031 54
5.6.2 Asia Pacific High Purity Taxifolin Sales Value by Region (%), 2024 VS 2031 55
5.7 South America 56
5.7.1 South America High Purity Taxifolin Sales Value, 2020-2031 56
5.7.2 South America High Purity Taxifolin Sales Value by Country (%), 2024 VS 2031 57
5.8 Middle East & Africa 58
5.8.1 Middle East & Africa High Purity Taxifolin Sales Value, 2020-2031 58
5.8.2 Middle East & Africa High Purity Taxifolin Sales Value by Country (%), 2024 VS 2031 59
6 Segmentation by Key Countries/Regions 60
6.1 Key Countries/Regions High Purity Taxifolin Sales Value Growth Trends, 2020 VS 2024 VS 2031 60
6.2 United States 62
6.2.1 United States High Purity Taxifolin Sales Value, 2020-2031 62
6.2.2 United States High Purity Taxifolin Sales Value by Type (%), 2024 VS 2031 63
6.2.3 United States High Purity Taxifolin Sales Value by Application, 2024 VS 2031 64
6.3 Europe 65
6.3.1 Europe High Purity Taxifolin Sales Value, 2020-2031 65
6.3.2 Europe High Purity Taxifolin Sales Value by Type (%), 2024 VS 2031 66
6.3.3 Europe High Purity Taxifolin Sales Value by Application, 2024 VS 2031 67
6.4 China 68
6.4.1 China High Purity Taxifolin Sales Value, 2020-2031 68
6.4.2 China High Purity Taxifolin Sales Value by Type (%), 2024 VS 2031 69
6.4.3 China High Purity Taxifolin Sales Value by Application, 2024 VS 2031 70
6.5 Japan 71
6.5.1 Japan High Purity Taxifolin Sales Value, 2020-2031 71
6.5.2 Japan High Purity Taxifolin Sales Value by Type (%), 2024 VS 2031 72
6.5.3 Japan High Purity Taxifolin Sales Value by Application, 2024 VS 2031 73
6.6 South Korea 74
6.6.1 South Korea High Purity Taxifolin Sales Value, 2020-2031 74
6.6.2 South Korea High Purity Taxifolin Sales Value by Type (%), 2024 VS 2031 75
6.6.3 South Korea High Purity Taxifolin Sales Value by Application, 2024 VS 2031 76
6.7 Southeast Asia 77
6.7.1 Southeast Asia High Purity Taxifolin Sales Value, 2020-2031 77
6.7.2 Southeast Asia High Purity Taxifolin Sales Value by Type (%), 2024 VS 2031 78
6.7.3 Southeast Asia High Purity Taxifolin Sales Value by Application, 2024 VS 2031 79
6.8 India 80
6.8.1 India High Purity Taxifolin Sales Value, 2020-2031 80
6.8.2 India High Purity Taxifolin Sales Value by Type (%), 2024 VS 2031 81
6.8.3 India High Purity Taxifolin Sales Value by Application, 2024 VS 2031 82
7 Company Profiles 83
7.1 Ametis JSC 83
7.1.1 Ametis JSC Company Information 83
7.1.2 Ametis JSC Introduction and Business Overview 84
7.1.3 Ametis JSC High Purity Taxifolin Sales, Revenue, Price and Gross Margin (2020-2025) 84
7.1.4 Ametis JSC High Purity Taxifolin Product Offerings 85
7.2 Jilin Jianwei Natural Biotechnology 86
7.2.1 Jilin Jianwei Natural Biotechnology Company Information 86
7.2.2 Jilin Jianwei Natural Biotechnology Introduction and Business Overview 86
7.2.3 Jilin Jianwei Natural Biotechnology High Purity Taxifolin Sales, Revenue, Price and Gross Margin (2020-2025) 87
7.2.4 Jilin Jianwei Natural Biotechnology High Purity Taxifolin Product Offerings 87
7.3 Kalenika Group 88
7.3.1 Kalenika Group Company Information 88
7.3.2 Kalenika Group Introduction and Business Overview 89
7.3.3 Kalenika Group High Purity Taxifolin Sales, Revenue, Price and Gross Margin (2020-2025) 89
7.3.4 Kalenika Group High Purity Taxifolin Product Offerings 90
7.4 ROBIOS 90
7.4.1 ROBIOS Company Information 90
7.4.2 ROBIOS Introduction and Business Overview 91
7.4.3 ROBIOS High Purity Taxifolin Sales, Revenue, Price and Gross Margin (2020-2025) 92
7.4.4 ROBIOS High Purity Taxifolin Product Offerings 92
7.5 Xi'an Sost Biotech Co.,Ltd 93
7.5.1 Xi'an Sost Biotech Co.,Ltd Company Information 93
7.5.2 Xi'an Sost Biotech Co.,Ltd Introduction and Business Overview 94
7.5.3 Xi'an Sost Biotech Co.,Ltd High Purity Taxifolin Sales, Revenue, Price and Gross Margin (2020-2025) 95
7.5.4 Xi'an Sost Biotech Co.,Ltd High Purity Taxifolin Product Offerings 95
7.6 Focusherb 96
7.6.1 Focusherb Company Information 96
7.6.2 Focusherb Introduction and Business Overview 97
7.6.3 Focusherb High Purity Taxifolin Sales, Revenue, Price and Gross Margin (2020-2025) 98
7.6.4 Focusherb High Purity Taxifolin Product Offerings 98
7.6.5 Focusherb Recent Development 99
7.7 Hoycome 99
7.7.1 Hoycome Company Information 100
7.7.2 Hoycome Introduction and Business Overview 100
7.7.3 Hoycome High Purity Taxifolin Sales, Revenue, Price and Gross Margin (2020-2025) 101
7.7.4 Hoycome High Purity Taxifolin Product Offerings 101
7.8 Herbchem Biotech 102
7.8.1 Herbchem Biotech Company Information 102
7.8.2 Herbchem Biotech Introduction and Business Overview 103
7.8.3 Herbchem Biotech High Purity Taxifolin Sales, Revenue, Price and Gross Margin (2020-2025) 103
7.8.4 Herbchem Biotech High Purity Taxifolin Product Offerings 104
8 Industry Chain Analysis 105
8.1 High Purity Taxifolin Industrial Chain 105
8.2 High Purity Taxifolin Upstream Analysis 105
8.2.1 Key Raw Materials 105
8.2.2 Raw Materials Key Suppliers 106
8.2.3 Manufacturing Process 106
8.3 Midstream Analysis 107
8.4 Downstream Analysis (Customers Analysis) 108
8.5 Sales Model and Sales Channels 108
8.5.1 High Purity Taxifolin Sales Model 108
8.5.2 Sales Channel 109
8.5.3 High Purity Taxifolin Distributors 109
9 Research Findings and Conclusion 110
10 Appendix 111
10.1 Research Methodology 111
10.1.1 Methodology/Research Approach 111
10.1.2 Data Source 114
10.2 Author Details 117
10.3 Disclaimer 118

 

ページTOPに戻る


 

Summary

The global High Purity Taxifolin market size was valued at US$ 26.74 million in 2024 and is forecast to reach US$ 35.66 million by 2031 with a CAGR of 4.06% during the forecast period 2025-2031.

The global key companies of High Purity Taxifolin include Ametis JSC, Jilin Jianwei Natural Biotechnology, Kalenika Group, ROBIOS, Xi'an Sost Biotech Co.,Ltd, Focusherb, Hoycome, etc. In 2024, the global five largest players hold a share approximately 91% in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for High Purity Taxifolin, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of High Purity Taxifolin by region & country, by Type, and by Application.
The High Purity Taxifolin market size, estimations, and forecasts are provided in terms of sales volume (kg) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding High Purity Taxifolin.

Market Segmentation
By Company
Ametis JSC
Jilin Jianwei Natural Biotechnology
Kalenika Group
ROBIOS
Xi'an Sost Biotech Co.,Ltd
Focusherb
Hoycome
Herbchem Biotech

Segment by Type
92%- 98%
Above 98%

Segment by Application
Healthcare
Food and Beverage
Cosmetics
Others

By Region
North America
United States
Canada
Mexico

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Rest of Asia-Pacific

Europe
Germany
France
UK
Italy
Russia
Rest of Europe

South America
Brazil
Rest of South America

Middle East & Africa
Middle East
Africa

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of High Purity Taxifolin manufacturer's competitive landscape, price, sales and revenue market share, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of High Purity Taxifolin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of High Purity Taxifolin in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.



ページTOPに戻る


Table of Contents

1 Market Overview 1
1.1 High Purity Taxifolin Product Introduction 1
1.2 Global High Purity Taxifolin Market Size Forecast 2
1.2.1 Global High Purity Taxifolin Sales Value (2020-2031) 2
1.2.2 Global High Purity Taxifolin Sales Volume (2020-2031) 3
1.2.3 Global High Purity Taxifolin Sales Price (2020-2031) 5
1.3 High Purity Taxifolin Market Trends & Drivers 5
1.3.1 High Purity Taxifolin Industry Trends 5
1.3.2 High Purity Taxifolin Market Drivers & Opportunity 6
1.3.3 High Purity Taxifolin Market Challenges 7
1.3.4 High Purity Taxifolin Market Restraints 7
1.4 Assumptions and Limitations 8
1.5 Study Objectives 9
1.6 Years Considered 10
2 Competitive Analysis by Company 11
2.1 Global High Purity Taxifolin Players Revenue Ranking (2024) 11
2.2 Global High Purity Taxifolin Revenue by Company (2020-2025) 12
2.3 Global High Purity Taxifolin Players Sales Volume Ranking (2024) 13
2.4 Global High Purity Taxifolin Sales Volume by Company Players (2020-2025) 14
2.5 Global High Purity Taxifolin Average Price by Company (2020-2025) 16
2.6 Key Manufacturers High Purity Taxifolin Manufacturing Base and Headquarters 16
2.7 Key Manufacturers High Purity Taxifolin Product Offered 17
2.8 Key High Purity Taxifolin Manufacturers, Established Time 17
2.9 High Purity Taxifolin Market Competitive Analysis 18
2.9.1 High Purity Taxifolin Market Concentration Rate (2020-2025) 18
2.9.2 Global 3 and 5 Largest Manufacturers by High Purity Taxifolin Revenue in 2024 19
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in High Purity Taxifolin as of 2024) 20
3 Segmentation by Type 22
3.1 Introduction by Type 22
3.1.1 92%- 98% 22
3.1.2 Above 98% 22
3.2 Global High Purity Taxifolin Sales Value by Type 22
3.2.1 Global High Purity Taxifolin Sales Value by Type (2020 VS 2024 VS 2031) 23
3.2.2 Global High Purity Taxifolin Sales Value, by Type (2020-2031) 24
3.2.3 Global High Purity Taxifolin Sales Value, by Type (%) (2020-2031) 25
3.3 Global High Purity Taxifolin Sales Volume by Type 26
3.3.1 Global High Purity Taxifolin Sales Volume by Type (2020 VS 2024 VS 2031) 26
3.3.2 Global High Purity Taxifolin Sales Volume, by Type (2020-2031) 28
3.3.3 Global High Purity Taxifolin Sales Volume, by Type (%) (2020-2031) 28
3.4 Global High Purity Taxifolin Average Price by Type (2020-2031) 29
4 Segmentation by Application 31
4.1 Introduction by Application 31
4.1.1 Healthcare 31
4.1.2 Food and Beverage 31
4.1.3 Cosmetics 32
4.1.4 Others 33
4.2 Global High Purity Taxifolin Sales Value by Application 34
4.2.1 Global High Purity Taxifolin Sales Value by Application (2020 VS 2024 VS 2031) 34
4.2.2 Global High Purity Taxifolin Sales Value, by Application (2020-2031) 36
4.2.3 Global High Purity Taxifolin Sales Value, by Application (%) (2020-2031) 37
4.3 Global High Purity Taxifolin Sales Volume by Application 38
4.3.1 Global High Purity Taxifolin Sales Volume by Application (2020 VS 2024 VS 2031) 38
4.3.2 Global High Purity Taxifolin Sales Volume, by Application (2020-2031) 40
4.3.3 Global High Purity Taxifolin Sales Volume, by Application (%) (2020-2031) 41
4.4 Global High Purity Taxifolin Average Price by Application (2020-2031) 42
5 Segmentation by Region 44
5.1 Global High Purity Taxifolin Sales Value by Region 44
5.1.1 Global High Purity Taxifolin Sales Value by Region: 2020 VS 2024 VS 2031 44
5.1.2 Global High Purity Taxifolin Sales Value by Region (2020-2025) 44
5.1.3 Global High Purity Taxifolin Sales Value by Region (2026-2031) 45
5.1.4 Global High Purity Taxifolin Sales Value by Region (%), (2020-2031) 45
5.2 Global High Purity Taxifolin Sales Volume by Region 46
5.2.1 Global High Purity Taxifolin Sales Volume by Region: 2020 VS 2024 VS 2031 46
5.2.2 Global High Purity Taxifolin Sales Volume by Region (2020-2025) 47
5.2.3 Global High Purity Taxifolin Sales Volume by Region (2026-2031) 47
5.2.4 Global High Purity Taxifolin Sales Volume by Region (%), (2020-2031) 48
5.3 Global High Purity Taxifolin Average Price by Region (2020-2031) 49
5.4 North America 50
5.4.1 North America High Purity Taxifolin Sales Value, 2020-2031 50
5.4.2 North America High Purity Taxifolin Sales Value by Country (%), 2024 VS 2031 51
5.5 Europe 52
5.5.1 Europe High Purity Taxifolin Sales Value, 2020-2031 52
5.5.2 Europe High Purity Taxifolin Sales Value by Country (%), 2024 VS 2031 53
5.6 Asia Pacific 54
5.6.1 Asia Pacific High Purity Taxifolin Sales Value, 2020-2031 54
5.6.2 Asia Pacific High Purity Taxifolin Sales Value by Region (%), 2024 VS 2031 55
5.7 South America 56
5.7.1 South America High Purity Taxifolin Sales Value, 2020-2031 56
5.7.2 South America High Purity Taxifolin Sales Value by Country (%), 2024 VS 2031 57
5.8 Middle East & Africa 58
5.8.1 Middle East & Africa High Purity Taxifolin Sales Value, 2020-2031 58
5.8.2 Middle East & Africa High Purity Taxifolin Sales Value by Country (%), 2024 VS 2031 59
6 Segmentation by Key Countries/Regions 60
6.1 Key Countries/Regions High Purity Taxifolin Sales Value Growth Trends, 2020 VS 2024 VS 2031 60
6.2 United States 62
6.2.1 United States High Purity Taxifolin Sales Value, 2020-2031 62
6.2.2 United States High Purity Taxifolin Sales Value by Type (%), 2024 VS 2031 63
6.2.3 United States High Purity Taxifolin Sales Value by Application, 2024 VS 2031 64
6.3 Europe 65
6.3.1 Europe High Purity Taxifolin Sales Value, 2020-2031 65
6.3.2 Europe High Purity Taxifolin Sales Value by Type (%), 2024 VS 2031 66
6.3.3 Europe High Purity Taxifolin Sales Value by Application, 2024 VS 2031 67
6.4 China 68
6.4.1 China High Purity Taxifolin Sales Value, 2020-2031 68
6.4.2 China High Purity Taxifolin Sales Value by Type (%), 2024 VS 2031 69
6.4.3 China High Purity Taxifolin Sales Value by Application, 2024 VS 2031 70
6.5 Japan 71
6.5.1 Japan High Purity Taxifolin Sales Value, 2020-2031 71
6.5.2 Japan High Purity Taxifolin Sales Value by Type (%), 2024 VS 2031 72
6.5.3 Japan High Purity Taxifolin Sales Value by Application, 2024 VS 2031 73
6.6 South Korea 74
6.6.1 South Korea High Purity Taxifolin Sales Value, 2020-2031 74
6.6.2 South Korea High Purity Taxifolin Sales Value by Type (%), 2024 VS 2031 75
6.6.3 South Korea High Purity Taxifolin Sales Value by Application, 2024 VS 2031 76
6.7 Southeast Asia 77
6.7.1 Southeast Asia High Purity Taxifolin Sales Value, 2020-2031 77
6.7.2 Southeast Asia High Purity Taxifolin Sales Value by Type (%), 2024 VS 2031 78
6.7.3 Southeast Asia High Purity Taxifolin Sales Value by Application, 2024 VS 2031 79
6.8 India 80
6.8.1 India High Purity Taxifolin Sales Value, 2020-2031 80
6.8.2 India High Purity Taxifolin Sales Value by Type (%), 2024 VS 2031 81
6.8.3 India High Purity Taxifolin Sales Value by Application, 2024 VS 2031 82
7 Company Profiles 83
7.1 Ametis JSC 83
7.1.1 Ametis JSC Company Information 83
7.1.2 Ametis JSC Introduction and Business Overview 84
7.1.3 Ametis JSC High Purity Taxifolin Sales, Revenue, Price and Gross Margin (2020-2025) 84
7.1.4 Ametis JSC High Purity Taxifolin Product Offerings 85
7.2 Jilin Jianwei Natural Biotechnology 86
7.2.1 Jilin Jianwei Natural Biotechnology Company Information 86
7.2.2 Jilin Jianwei Natural Biotechnology Introduction and Business Overview 86
7.2.3 Jilin Jianwei Natural Biotechnology High Purity Taxifolin Sales, Revenue, Price and Gross Margin (2020-2025) 87
7.2.4 Jilin Jianwei Natural Biotechnology High Purity Taxifolin Product Offerings 87
7.3 Kalenika Group 88
7.3.1 Kalenika Group Company Information 88
7.3.2 Kalenika Group Introduction and Business Overview 89
7.3.3 Kalenika Group High Purity Taxifolin Sales, Revenue, Price and Gross Margin (2020-2025) 89
7.3.4 Kalenika Group High Purity Taxifolin Product Offerings 90
7.4 ROBIOS 90
7.4.1 ROBIOS Company Information 90
7.4.2 ROBIOS Introduction and Business Overview 91
7.4.3 ROBIOS High Purity Taxifolin Sales, Revenue, Price and Gross Margin (2020-2025) 92
7.4.4 ROBIOS High Purity Taxifolin Product Offerings 92
7.5 Xi'an Sost Biotech Co.,Ltd 93
7.5.1 Xi'an Sost Biotech Co.,Ltd Company Information 93
7.5.2 Xi'an Sost Biotech Co.,Ltd Introduction and Business Overview 94
7.5.3 Xi'an Sost Biotech Co.,Ltd High Purity Taxifolin Sales, Revenue, Price and Gross Margin (2020-2025) 95
7.5.4 Xi'an Sost Biotech Co.,Ltd High Purity Taxifolin Product Offerings 95
7.6 Focusherb 96
7.6.1 Focusherb Company Information 96
7.6.2 Focusherb Introduction and Business Overview 97
7.6.3 Focusherb High Purity Taxifolin Sales, Revenue, Price and Gross Margin (2020-2025) 98
7.6.4 Focusherb High Purity Taxifolin Product Offerings 98
7.6.5 Focusherb Recent Development 99
7.7 Hoycome 99
7.7.1 Hoycome Company Information 100
7.7.2 Hoycome Introduction and Business Overview 100
7.7.3 Hoycome High Purity Taxifolin Sales, Revenue, Price and Gross Margin (2020-2025) 101
7.7.4 Hoycome High Purity Taxifolin Product Offerings 101
7.8 Herbchem Biotech 102
7.8.1 Herbchem Biotech Company Information 102
7.8.2 Herbchem Biotech Introduction and Business Overview 103
7.8.3 Herbchem Biotech High Purity Taxifolin Sales, Revenue, Price and Gross Margin (2020-2025) 103
7.8.4 Herbchem Biotech High Purity Taxifolin Product Offerings 104
8 Industry Chain Analysis 105
8.1 High Purity Taxifolin Industrial Chain 105
8.2 High Purity Taxifolin Upstream Analysis 105
8.2.1 Key Raw Materials 105
8.2.2 Raw Materials Key Suppliers 106
8.2.3 Manufacturing Process 106
8.3 Midstream Analysis 107
8.4 Downstream Analysis (Customers Analysis) 108
8.5 Sales Model and Sales Channels 108
8.5.1 High Purity Taxifolin Sales Model 108
8.5.2 Sales Channel 109
8.5.3 High Purity Taxifolin Distributors 109
9 Research Findings and Conclusion 110
10 Appendix 111
10.1 Research Methodology 111
10.1.1 Methodology/Research Approach 111
10.1.2 Data Source 114
10.2 Author Details 117
10.3 Disclaimer 118

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(ケミカル)の最新刊レポート


よくあるご質問


QYResearch社はどのような調査会社ですか?


QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。   QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2025/05/21 10:26

145.28 円

164.45 円

197.45 円

ページTOPに戻る